| 39.83 BATS BZX Real-Time Price As of 11:19am ET |  +0.155 / +0.39%Today’s Change | 34.38 Today|||52-Week Range 43.30 | +4.86% Year-to-Date |
| Previous close | 39.67 |
| Today’s open | 39.59 |
| Day’s range | 39.57 - 39.83 |
| Volume | 500,368 |
| Average volume (3 months) | 4,881,767 |
| Market cap | $104.1B |
| Earnings growth (last year) | -29.11% |
| Earnings growth (this year) | +2.07% |
| Earnings growth (next 5 years) | +15.10% |
| Revenue growth (last year) | -2.88% |
| P/E ratio | 41.9 |
| Price/Sales | 4.36 |
| Price/Book | 8.06 |
| Today’s change | Today’s % change | |
|---|---|---|
| SNYSanofi | +0.01 | +0.02% |
| GSKGlaxoSmithKline | -0.13 | -0.32% |
| LLYEli Lilly and Co | +0.89 | +0.80% |
| NVONovo Nordisk | +0.37 | +0.73% |
| Next reporting date | October 24, 2019 |
| EPS forecast (this quarter) | $0.35 |
| Annual revenue (last year) | $22.1B |
| Annual profit (last year) | $2.2B |
| Net profit margin | 9.76% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chief Executive Officer & Executive Director Pascal Soriot |
Executive VP-Operations & Information Technology Pam P. Cheng |
Corporate headquarters Cambridge, Cambridgeshire |
